Analysts expect Aprea Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00, a 100.0% miss against the 261,774.04 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 354,620.00 | 205,820.00 | 162,460.00 | 118,110.00 | 1,850.00 | 3,340.00 | 140,500.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 235,349.53 | 230,534.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 272,216.47 | 0.00 | 0.00 | 994,357.01 | 1.12 M | 356,178.10 | 101,211.13 | 115,792.50 | 396,544.34 | ||||||||||
| Low Estimate | 199,352.71 | 191,882.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 251,331.61 | 0.00 | 0.00 | 837,603.47 | 981,506.35 | 330,765.98 | 84,623.19 | 99,804.68 | 332,663.54 | ||||||||||
| Consensus Estimate | 217,351.12 | 211,208.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 261,774.04 | 0.00 | 0.00 | 915,980.24 | 1.05 M | 343,472.04 | 92,917.16 | 107,798.59 | 364,603.94 |
Analysts expect Aprea Therapeutics, Inc. to report earnings per share of -0.07 for Q3 26, against a range of -0.07 to -0.07. The most recent reported quarter, Q2 26, came in at -0.07, a 63.2% beat against the -0.19 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.64 | -0.49 | -0.66 | -0.53 | -0.47 | -0.32 | -0.22 | -0.07 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.69 | -0.59 | -0.59 | -0.62 | -0.35 | -0.38 | -0.18 | -0.17 | -0.07 | -0.06 | -0.08 | -0.08 | 0.00 | 0.04 | -0.14 | -0.10 | ||||||||||
| Low Estimate | -0.79 | -0.65 | -0.69 | -0.70 | -0.37 | -0.44 | -0.22 | -0.21 | -0.07 | -0.08 | -0.08 | -0.08 | 0.00 | 0.04 | -0.16 | -0.12 | ||||||||||
| Consensus Estimate | -0.74 | -0.62 | -0.64 | -0.66 | -0.36 | -0.41 | -0.20 | -0.19 | -0.07 | -0.07 | -0.08 | -0.08 | 0.00 | 0.04 | -0.15 | -0.11 |
Pull Wall Street consensus for Aprea Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=APRE&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "APRE", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=APRE&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();